Strafford will be offering a webinar entitled "Obtaining and Managing REMS Patents: What Patent Prosecutors Need to Know, USPTO and FDA Policies and Rules" on March 21, 2023 from 1:00 to 2:30 pm (EDT). Joanna T. Broughet of BioPharma Law Group and Mark J. Feldstein, Thomas L. Irving, and Adriana L. Burgy of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the issues surrounding Risk Evaluation and Mitigation Strategy (REMS) patents and listing in the Orange Book, discuss REMS patents and what patent prosecutors need to know, address the current efforts of the USPTO and FDA to determine what policy or rules will govern the listing of REMS patents, discuss other issued patents relating to REMS, and offer best practices for obtaining and managing REMS patents. The webinar will review the following issues:
• What are the considerations for patent counsel when deciding whether to list a REMS patent in the Orange Book?
• What is the significance of the FTC intervention in the Jazz case?
• What best practices should counsel employ when obtaining and managing REMS patents?
The registration fee for the webcast is $347. Those interested in registering for the webinar, can do so here.
Comments